— OUR STORY

Built to solve a
life-or-death access gap.

Brachytherapy is standard of care, curative treatment for cervical cancer — delivering radiation precisely to a tumor and dramatically improving survival rates. Yet nearly half of patients who need it never access or complete treatment.

The barriers are systemic: too few trained practitioners, insufficient medical device equipment solutions, access disparities and a clinical education gap that leaves providers under-resourced to deliver the safest, most effective treatment.

Mission-Driven Tech™ was built to change that. With our next-generation brachytherapy medical device currently in development, we’re not waiting to address procedure safety and outcome improvements. BrachyStories®, our CME-accredited clinical education and Happy Cervix™ retail products are designed to address critical gaps in awareness and education, while fueling our research & development roadmap.

At MDT we’ve built a wide coalition of support for brachytherapy innovation. We partner with trailblazing clinicians, leading research institutions and global health organizations — all united by the belief that cervical cancer patients deserve the best outcomes that modern medicine and technology can offer.

Mission–Driven Tech^™

Every Innovation
Saves Lives.

Building the future
of brachytherapy.

Founded

R&D studies @ Brachy
Treatment Sites

Funding raised

A Cervical Cancer Innovation Company •

— THE CASE FOR BRACHYTHERAPY INNOVATION

Born from urgency

Brachytherapy is one of the most effective treatments for cervical cancer — delivering radiation precisely to the tumor with dramatically better survival rates. Yet nearly half of patients who need it never complete treatment.

The barriers are systemic: too few trained providers, insufficient equipment, access disparities across geography and socioeconomic status, and a clinical education gap that leaves providers underprepared to advocate for the treatment.

Mission-Driven Tech™ was built to change that. Our work spans CME-accredited clinical education (BrachyStories®), patient empowerment and awareness (Happy Cervix™), equitable technology licensing (MDTechTerms™), and a next-generation brachytherapy device currently in R&D.

We partner with leading research universities, cancer societies, and global health organizations — all united by the belief that no patient should die from a cancer with a known, effective treatment.